Morgan Stanley Maintains Lemonade(LMND.US) With Sell Rating, Cuts Target Price to $14
Morgan Stanley Reaffirms Their Sell Rating on Lemonade (LMND)
Lemonade, Inc. (LMND) Revolutionizes Insurance With AI-Powered Claims Processing, Fraud Detection, and Personalized Pricing
VINEYARD VINES PARTNERS WITH THE BREAST CANCER RESEARCH FOUNDATION AND THE PINK LEMONADE STAND CHALLENGE
NEW SURVEY FROM TRUE LEMON KIDS REVEALS THE IMPORTANCE OF HYDRATION DURING THE SCHOOL YEAR
Institutional Investors in Lemonade, Inc. (NYSE:LMND) Lost 4.5% Last Week but Have Reaped the Benefits of Longer-term Growth